Spero Therapeutics to Present at Upcoming Investor
CAMBRIDGE, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero), a multi-asset
Globe Newswire28-02-2023, 20:11
Dr. Maureen Dunne Invited as Keynote Speaker at Global 14-02-2023, 09:03